What Clovis Oncology’s Bottom Line Trend Indicates

What Clovis Oncology’s Bottom Line Trend Indicates

While Clovis received an income tax benefit of $1.23 million in the third quarter of 2017, it incurred an income tax expense of $13,000 in the third quarter of 2018. Clovis Oncology had a net income of -$90.37 million in the third quarter compared to -$59.06 million in the third quarter of 2017. Clovis Oncology’s net EPS were $1.24 in the third quarter of 2017.